BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1970755)

  • 1. The beta-adrenergic pathway in the failing human heart: implications for inotropic therapy.
    Feldman AM; Bristow MR
    Cardiology; 1990; 77 Suppl 1():1-32. PubMed ID: 1970755
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale for beta-adrenergic blocking drugs in cardiomyopathy.
    Fowler MB; Bristow MR
    Am J Cardiol; 1985 Apr; 55(10):120D-124D. PubMed ID: 2859789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the beta-adrenergic signaling pathway in human heart failure.
    Hamdani N; Linke WA
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2522-31. PubMed ID: 22280427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paradox of beta-adrenergic blockade for the management of congestive heart failure.
    Eichhorn EJ
    Am J Med; 1992 May; 92(5):527-38. PubMed ID: 1349791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do beta-blockers improve ventricular function in patients with congestive heart failure?
    Barry WH; Gilbert EM
    Circulation; 2003 May; 107(19):2395-7. PubMed ID: 12756189
    [No Abstract]   [Full Text] [Related]  

  • 6. [Importance of beta 2-adrenergic receptors in heart failure].
    Brodde OE; Daul A; Michel MC; Zerkowski HR
    Z Kardiol; 1992; 81 Suppl 4():71-8. PubMed ID: 1363262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors].
    Witkowska M
    Kardiol Pol; 1982; 25(2):147-61. PubMed ID: 6125621
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenergic receptors: new concepts and implications for cardiovascular therapeutics.
    Colucci WS; Braunwald E
    Cardiovasc Clin; 1984; 14(3):39-59. PubMed ID: 6144390
    [No Abstract]   [Full Text] [Related]  

  • 9. Inotropic drugs for treatment of the failing heart.
    Maskin CS; Le Jemtel TH; Sonnenblick EH
    Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of cardiac glycosides and the process of adrenergic mediation (a review of the literature)].
    Frantsuzova SB
    Farmakol Toksikol; 1977; 40(6):733-45. PubMed ID: 23310
    [No Abstract]   [Full Text] [Related]  

  • 11. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sympathetic nervous system in chronic heart failure.
    Joseph J; Gilbert EM
    Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):9-16. PubMed ID: 9715818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.
    Bristow MR; Hershberger RE; Port JD; Gilbert EM; Sandoval A; Rasmussen R; Cates AE; Feldman AM
    Circulation; 1990 Aug; 82(2 Suppl):I12-25. PubMed ID: 2164894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adrenergic activation in heart failure: blockade or rebalance?].
    Emdin M; Vergaro G; Giannoni A; Passino C
    G Ital Cardiol (Rome); 2010 Mar; 11(3):229-32. PubMed ID: 20550063
    [No Abstract]   [Full Text] [Related]  

  • 15. [How is catecholamine therapy carried out in heart failure?].
    Reek S
    Dtsch Med Wochenschr; 2002 Oct; 127(40):2087-8. PubMed ID: 12373645
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-adrenoceptor polymorphisms and heart failure.
    Lohse MJ
    Trends Mol Med; 2004 Feb; 10(2):55-8. PubMed ID: 15106619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in cardiac myocyte function by biological effects of medical therapy: a new concept in the treatment of heart failure.
    Bristow MR; Gilbert EM
    Eur Heart J; 1995 Jul; 16 Suppl F():20-31. PubMed ID: 8521881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E; Schwinger R; Böhm M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta-adrenergic receptor-adenylate cyclase complex as a target for therapeutic intervention in heart failure.
    Bristow MR; Port JD; Hershberger RE; Gilbert EM; Feldman AM
    Eur Heart J; 1989 Jun; 10 Suppl B():45-54. PubMed ID: 2572420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympatholysis and cardiac sympathetic nerve function in the treatment of congestive heart failure.
    Liang CS
    J Am Coll Cardiol; 2003 Aug; 42(3):549-51. PubMed ID: 12906987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.